newborn
lung
suscept
bacteri
viral
infect
neonat
pneumonia
major
caus
morbid
mortal
worldwid
infant
age
year
die
pneumonia
annual
although
number
repres
declin
earlier
estim
neonat
pneumonia
remain
consider
global
health
burden
fall
disproportion
develop
countri
diagnos
pneumonia
newborn
period
challeng
compar
older
children
neonat
show
fewer
local
sign
pulmonari
infect
pneumonia
frequent
manifest
system
deterior
involv
multipl
organ
system
common
noninfecti
respiratori
complic
prematur
often
coexist
exacerb
pneumonia
may
cloud
clinic
impress
even
pneumonia
suspect
technic
barrier
lower
airway
sampl
small
infant
may
render
conclus
identif
etiolog
organ
imposs
necessit
care
reason
empir
therapi
review
cover
risk
factor
pathophysiolog
diagnosi
treatment
neonat
pneumonia
discuss
organ
around
three
diseas
subtyp
distinguish
age
present
rout
acquisit
major
caus
microorgan
subtyp
congenit
pneumonia
infect
establish
fetal
life
may
result
ascend
infect
across
chorioamniot
membran
hematogen
transplacent
rout
earlyonset
pneumonia
develop
within
first
week
life
result
perinat
pathogen
exposur
either
intrauterin
passag
birth
canal
lateonset
pneumonia
includ
ventilatorassoci
pneumonia
vap
develop
first
week
life
environment
often
nosocomi
pathogen
exposur
compar
children
adult
newborn
limit
capac
defend
pulmonari
infect
immatur
innat
immun
e
system
local
respiratori
mucosa
lung
parenchyma
e
fundament
risk
factor
neonat
pneumonia
signific
prematur
growthrestrict
patient
adapt
immun
e
mostli
form
matern
deriv
igg
e
rudimentari
immedi
newborn
period
adapt
immun
requir
antigen
exposur
molecular
refin
infanc
childhood
order
establish
strong
protect
structur
newborn
lung
key
defici
import
barrier
function
provid
first
line
defens
infect
rel
pauciti
resid
alveolar
macrophag
coupl
impair
mucociliari
clearanc
debri
permit
establish
earli
colon
potenti
pathogen
surfact
defici
due
prematur
link
enhanc
growth
group
b
streptococcu
gb
deterior
anim
model
escherichia
coli
pneumonia
also
evid
pulmonari
infect
inactiv
exist
surfact
damag
type
ii
pneumocyt
prevent
replenish
surfact
replac
therapi
shown
improv
oxygen
patient
gb
pneumonia
phagocytosi
neutrophil
recruit
lung
essenti
first
step
clear
pulmonari
bacteri
infect
neonat
show
multipl
form
neutrophil
dysfunct
base
dataset
measur
healthi
subject
term
preterm
newborn
neutropenia
absolut
neutrophil
count
baselin
newborn
also
exhibit
blunt
neutrophil
recruit
bone
marrow
respons
infect
defect
neutrophil
chemotaxi
site
inflamm
neutrophil
deriv
preterm
infant
especi
affect
effici
pathogen
clearanc
recruit
neutrophil
resid
phagocyt
e
macrophag
monocyt
e
depend
opson
complement
antibodi
nonspecif
bind
protein
includ
fibronectin
creactiv
protein
crp
mannosebind
lectin
addit
facilit
effect
phagocytosi
complement
also
import
direct
microbicid
activ
format
membran
attack
complex
promot
recognit
host
cell
harbor
intracellular
pathogen
bacteri
viral
unfortun
neonat
lower
level
mani
complement
compon
lack
specif
antibodi
accessori
opsonin
limit
capabl
innat
immun
system
mount
effect
respons
pneumonia
congenit
pneumonia
result
matern
infect
pregnanc
typic
present
one
compon
system
ill
congenit
toxoplasmosi
due
primari
matern
infect
intracellular
protozoa
toxoplasma
gondii
main
matern
risk
factor
eat
undercook
meat
exposur
cat
fece
pregnanc
risk
transmiss
fetu
increas
gestat
age
sever
congenit
ill
e
includ
pneumonia
e
decreas
pregnanc
progress
neonat
pneumonia
may
one
manifest
congenit
cytomegaloviru
cmv
infect
affect
pregnanc
seroneg
mother
develop
primari
cmv
infect
pregnanc
highest
risk
deliv
affect
newborn
transplacent
transmiss
rate
risk
vertic
transmiss
highest
matern
infect
occur
first
half
pregnanc
wherea
seroposit
mother
experi
cmv
reactiv
pregnanc
risk
vertic
transmiss
among
group
sever
often
hemorrhag
viral
pneumon
may
one
manifest
dissemin
herp
simplex
viru
hsv
infect
pulmonari
symptom
uncommon
skineeyeemouth
central
nervou
system
diseas
two
form
neonat
hsv
diseas
respiratori
distress
present
featur
approxim
half
dissemin
hsv
case
typic
begin
first
two
week
life
neonat
dissemin
hsv
infect
usual
result
ascend
intrauterin
infect
intrapartum
exposur
infect
genit
tract
major
risk
factor
neonat
hsv
vagin
deliveri
set
primari
matern
infect
either
cesarean
section
prior
matern
exposur
either
hsv
subtyp
reduc
risk
transmiss
consider
demograph
risk
factor
matern
hsv
infect
includ
africanor
mexicanamerican
ethnic
past
histori
sexual
transmit
infect
poverti
risk
correl
directli
age
number
lifetim
sexual
partner
invers
degre
educ
risk
factor
earlyonset
bacteri
pneumonia
overlap
earlyonset
bacteremia
mening
box
reflect
share
pathogen
mechan
discuss
section
chorioamnion
key
risk
factor
earlyonset
infect
includ
pneumonia
inflamm
decidua
chorioamniot
membran
often
signal
microbi
invas
fetoplacent
unit
accompani
power
fetal
inflammatori
respons
syndrom
fir
induc
structur
remodel
lungsdlead
simplif
cellular
architectur
increas
odd
later
pneumonia
chronic
lung
diseas
chorioamnion
fir
may
also
trigger
preterm
ruptur
membran
preterm
labor
deliveri
compound
infecti
risk
major
risk
factor
lateonset
pneumonia
e
includ
vap
e
prematur
low
birth
weight
durat
mechan
ventil
sinc
risk
often
correl
difficult
conclus
establish
independ
contribut
differ
studi
reach
vari
conclus
longitudin
studi
neonat
nosocomi
infect
identifi
significantli
increas
risk
pneumonia
among
patient
birth
weight
g
howev
prospect
studi
vap
almost
neonat
intub
least
h
identifi
durat
mechan
ventil
sole
independ
risk
factor
pneumonia
risk
factor
vap
includ
prior
bloodstream
infect
low
nurs
patient
ratio
inadequ
environment
air
filtrat
frequent
suction
eight
time
per
day
sedat
intub
amniot
fluid
moder
incomplet
microbicid
modest
level
antivir
cytokin
acut
intrauterin
infect
bacteri
viral
growth
occur
amniot
fluid
allow
direct
contact
pathogen
fetal
risk
factor
earlyonset
pneumonia
prematur
low
birth
weight
low
socioeconom
statu
male
gender
colon
known
pathogen
eg
group
b
streptococcu
prolong
ruptur
membran
h
galactosemia
increas
suscept
infect
gramneg
organ
prematur
ruptur
membran
chorioamnion
respiratori
mucosa
addit
demonstr
caus
microorgan
patholog
examin
lung
stillborn
newborn
die
earlyonset
pneumonia
routin
identifi
leukocyt
matern
origin
aspir
amniot
debri
support
concept
congenit
earlyonset
pneumonia
may
aris
direct
mucos
seed
infect
amniot
fluid
meconium
aspir
increas
risk
pneumonia
decreas
antimicrobi
properti
amniot
fluid
serv
vector
bacteri
entri
postnat
persist
lung
anoth
opportun
pathogen
enter
neonat
respiratori
tract
occur
passag
birth
canal
matern
vagin
colon
gb
key
risk
factor
develop
earlyonset
gb
sepsi
often
includ
pneumonia
absenc
prophylact
antibiot
infant
born
gbscolon
mother
becom
colon
intrapartum
aspir
respiratori
secret
contain
gb
willdin
small
subsetdprogress
pulmonari
infect
quickli
lead
hematogen
spread
evolut
fullblown
sepsi
progress
intrapartum
mucos
colon
earlyonset
pneumonia
identifi
escherichia
coli
chlamydia
trachomati
pneumococcu
pneumonia
haemophilu
influenza
major
pathogen
respons
congenit
earlyonset
pneumonia
list
box
lateonset
pneumonia
result
colon
oropharyng
mucosa
potenti
pathogen
seed
lower
respiratori
tract
inadequ
immun
defens
permit
dissemin
lateonset
pneumonia
develop
hospit
may
term
healthcareassoci
pneumonia
previous
nosocomi
pneumonia
distinct
epidemiolog
lateonset
pneumonia
occur
discharg
multipli
drugresist
bacteria
frequent
caus
healthcareassoci
pneumonia
wherea
communityacquir
viral
infect
respiratori
synctiti
viru
rsv
parainfluenza
adenoviru
frequent
caus
lateonset
pneumonia
home
set
box
list
frequent
occur
lateonset
pneumonia
pathogen
sourc
initi
oropharyng
colon
lead
pneumonia
exogen
endogen
common
exogen
sourc
includ
caretak
skin
usual
hand
medic
profession
contamin
equip
environment
surfac
strong
evid
inadequ
hand
hygien
major
contributor
healthcareassoci
neonat
pneumonia
two
larg
observ
studi
compar
nosocomi
infect
rate
introduct
intens
handwash
improv
initi
show
signific
decreas
neonat
vap
rate
main
endogen
sourc
microorgan
respons
lateonset
pneumonia
nasal
oropharyng
mucosa
pool
oral
secret
posterior
oropharynx
foster
local
overgrowth
pathogen
speci
whose
subsequ
aspir
set
stage
pneumonia
intub
e
perhap
sedat
e
newborn
uncuf
endotrach
tube
ett
high
risk
passag
infect
secret
lower
airway
necessit
care
attent
headofb
elev
adequ
tracheal
suction
reflux
aspir
contamin
gastric
secret
repres
anoth
potenti
rout
pulmonari
infect
exact
role
gastric
bacteria
pneumonia
pathogenesi
remain
controversi
tracheal
fluid
intub
infant
shown
contain
gastric
pepsin
concentr
vari
invers
degre
head
elev
studi
intub
adult
underw
technetium
label
gastric
content
follow
scintigraphi
endotrach
suction
sampl
also
demonstr
migrat
gastric
fluid
airway
found
supin
posit
exacerb
aspir
howev
studi
adult
suggest
gastric
bacteria
may
contribut
significantli
healthcareassoci
pneumonia
two
research
group
perform
serial
microbiolog
sampl
trachea
pharynx
stomach
intub
adult
one
studi
subject
develop
vap
also
underw
bronchoalveolar
lavag
bal
examin
cultur
result
differ
site
allow
tempor
reconstruct
bacteri
popul
dynam
support
theori
frequent
migrat
gastric
bacteria
airway
occur
furthermor
none
patient
develop
vap
grew
bacteria
gastric
origin
bal
sampl
caus
congenit
earlyonset
pneumonia
among
intub
infant
ett
repres
import
reservoir
microorgan
sever
studi
demonstr
earli
progress
growth
bacteri
biofilm
outer
lumin
surfac
neonat
ett
particular
concern
reliabl
find
ett
biofilm
tend
enrich
potenti
pathogen
speci
staphylococcu
aureu
varieti
gramneg
bacilli
patient
vap
show
high
correl
microorgan
colon
ett
cultur
tracheal
secret
suggest
ett
biofilm
probabl
sourc
infect
furthermor
artifici
surfac
ett
complex
threedimension
biofilm
ett
colon
subsist
increas
bacteri
resist
antibiot
therapi
final
ett
serv
foreign
bodi
impair
mucociliari
transport
prevent
effect
cough
limit
debri
clearanc
lower
airway
bacteri
viral
growth
distal
airway
result
inflammatori
respons
lead
cellular
injuri
impair
ga
exchang
alter
pulmonari
circul
interfer
normal
respiratori
mechan
case
bacteri
pneumonia
initi
cellular
injuri
result
direct
exposur
bacteriasecret
surfaceassoci
toxin
cmv
dissemin
hsv
trigger
lytic
apoptot
loss
pneumocyt
serv
viral
host
cell
pulmonari
infect
denud
alveolar
surfac
interfer
surfact
function
allow
transud
pulmonari
edema
culmin
alveolar
collaps
inflammatori
respons
trigger
pulmonari
infect
may
also
caus
signific
injuri
dysfunct
neutrophil
recruit
lung
serv
primarili
antimicrobi
phagocyt
also
secret
reactiv
oxygen
speci
tissuedamag
molecul
elastas
urokinas
particularli
true
senesc
neutrophil
evid
defect
neonat
neutrophil
apoptosi
may
render
danger
host
tissu
neutrophil
adult
airway
obstruct
bacteri
inflammatori
debri
e
combin
smooth
muscl
contract
due
inflammatori
mediat
e
impair
effect
ventil
promot
atelectasi
air
trap
subsequ
ventilationeperfus
mismatch
inflammatori
procoagul
vasoconstrictor
releas
activ
endotheli
cell
platelet
increas
pulmonari
vascular
resist
potenti
trigger
pulmonari
hypertens
crisi
alreadi
limit
surfact
pool
fail
clinic
manifest
spiral
infecti
immun
process
sever
ill
patient
fail
respiratori
circulatori
system
diagnosi
neonat
pneumonia
base
combin
physic
exam
find
radiograph
evid
support
laboratori
data
center
diseas
control
prevent
cdc
criteria
diagnos
pneumonia
patient
age
year
radiograph
evid
persist
consolid
cavit
pleural
effus
evid
worsen
ga
exchang
plu
least
three
addit
clinic
andor
laboratori
find
box
vap
may
diagnos
patient
intub
least
h
meet
criteria
pneumonia
recent
intern
work
group
develop
case
definit
signific
neonat
infect
includ
pneumonia
diagnost
criteria
pneumonia
align
cdc
also
provid
guidelin
diagnosi
resourcelimit
environ
unlik
frequent
occur
neonat
infect
bacteremia
mening
microbiolog
identif
singl
pathogen
caus
pneumonia
often
possibl
invas
lower
airway
cultur
method
blind
bal
bronchoscopi
protect
brush
sampl
sometim
use
pediatr
adult
icu
howev
technic
challeng
increas
risk
associ
perform
techniqu
neonat
invas
airway
sampl
consid
firstlin
diagnost
approach
neonat
intens
care
unit
pneumonia
may
lead
hematogen
seed
bacteremia
posit
blood
cultur
neither
necessari
suffici
diagnos
pneumonia
clinic
laboratori
assess
suction
tracheal
sputum
sampl
intub
patient
may
help
diagnos
neonat
pneumonia
select
empir
antibiot
treatment
regimen
increas
product
purul
sputum
import
diagnost
criterion
frequent
present
sign
neonat
pneumonia
cultur
tracheal
sputum
rare
yield
singl
organ
indic
tracheal
secret
usual
harbor
varieti
colon
speci
addit
pathogen
might
present
howev
gram
stain
tracheal
sputum
show
leukocyt
infiltr
predomin
singl
bacteri
morphotyp
eg
gramposit
cocci
pair
chain
gb
suggest
pneumonia
caus
domin
microb
may
inform
initi
treatment
furthermor
serial
gram
stain
suction
sputum
treatment
may
use
track
diseas
resolut
persist
singl
e
potenti
drugresist
e
organ
newborn
system
diseas
pneumonia
prompt
consider
congenit
infect
cmv
hsv
box
cdcnni
definit
pneumonia
must
meet
criteria
three
categori
underli
pulmonari
cardiac
diseas
two
serial
xray
demonstr
least
one
follow
toxoplasma
evalu
includ
liver
function
test
includ
coagul
profil
urin
cultur
cmv
surfac
cultur
hsv
lumbar
punctur
csf
cell
count
differenti
cultur
polymeras
chain
reaction
pcr
hsv
toxoplasma
concern
toxoplasmosi
cmv
high
evalu
includ
cranial
imag
antibodi
titer
infant
mother
may
confirm
recent
exposur
lateonset
pneumonia
caus
viral
infect
may
indistinguish
bacteri
diseas
recent
prospect
studi
found
infant
suspect
lateonset
sepsi
viral
infect
varieti
highsensit
highspecif
pcrand
enzymelink
immunosorb
assay
elisa
base
assay
exist
specif
viral
test
mani
hospit
run
comprehens
rapid
multiplex
test
singl
sampl
suction
pharyng
sputum
regardless
age
diseas
onset
treatment
suspect
bacteri
pneumonia
begin
immedi
empir
antibiot
regimen
broad
enough
cover
like
etiolog
organ
includ
may
drug
resist
inform
becom
avail
initi
coverag
narrow
much
possibl
limit
drawback
prolong
exposur
broadspectrum
antibiot
case
earlyonset
pneumonia
ampicillin
aminoglycosid
gentamicin
appropri
start
regimen
cefotaxim
may
substitut
gentamicin
strong
suspicion
concurr
bacteri
mening
signific
concern
hsv
acyclovir
start
immedi
standard
treatment
congenit
toxoplasmosi
pyrimethamin
sulfadiazin
plu
folin
acid
one
year
age
recent
recommend
treatment
infant
congenit
cmv
suggest
least
six
month
treatment
valganciclovir
limit
extent
neurolog
sequela
infant
symptomat
cmv
infect
choos
empir
antibiot
suspect
lateonset
bacteri
pneumonia
requir
nuanc
thought
must
given
local
pattern
bacteri
antibiot
resist
patient
histori
previou
infect
known
colon
antibiot
exposur
might
select
drugresist
organ
minimum
initi
therapi
includ
two
antibiot
coverag
drugresist
gramposit
gramneg
speci
one
antibiot
must
activ
meticillinresist
staphylococcu
aureu
mrsa
frequent
caus
vap
associ
poor
clinic
outcom
vancomycin
linezolid
accept
antimrsa
choic
although
two
antibiot
never
compar
headtohead
trial
treatment
neonat
vap
evid
pediatr
adult
literatur
suggest
linezolid
may
higher
efficaci
vancomycin
accept
choic
second
antibiot
includ
piperacillintazobactam
gentamicin
although
possibl
may
valid
depend
situat
sever
ill
patient
lateonset
pneumonia
start
threedrug
regimen
potenti
combin
suggest
tabl
antibiot
therapi
continu
minimum
day
longer
treatment
may
warrant
case
sever
persist
ill
concurr
infect
beyond
lung
limit
studi
compar
differ
treatment
durat
yield
clear
consensu
optim
cours
adult
studi
compar
treatment
vap
found
signific
differ
mortal
relaps
rate
howev
subset
patient
vap
caus
gramneg
nonfer
bacilli
receiv
cours
higher
relaps
rate
cours
therapi
reason
start
point
uncompl
pneumonia
may
modifi
circumst
requir
american
thorac
societi
infecti
diseas
societi
america
publish
guidelin
reduc
incid
hospitalacquir
pneumonia
includ
vap
recommend
focu
limit
opportun
crosscontamin
caregiv
patient
decreas
tissu
damag
prolong
recurr
intub
avoid
unnecessari
medic
may
promot
infect
andor
antibiot
resist
maxim
oral
hygien
pulmonari
toilet
mani
hospit
adopt
vap
bundl
consist
multipl
simultan
practic
e
appli
univers
intub
patient
e
intend
minim
risk
infect
current
standard
neonat
vap
bundl
practic
vari
among
unit
level
evid
bundl
compon
howev
overal
evid
suggest
care
bundl
reduc
risk
vap
box
summar
vap
bundl
element
implement
neonat
popul
tabl
initi
empir
therapi
ventilatorassoci
pneumonia
patient
signific
risk
factor
multidrugresist
pathogen
combin
antibiot
therapi
pneumonia
frequent
form
infect
among
hospit
neonat
sporad
affect
newborn
without
addit
risk
factor
age
onset
surround
circumst
includ
matern
histori
may
provid
import
clue
etiolog
may
help
guid
initi
treatment
decis
earli
intervent
broadspectrum
antibiot
crucial
prevent
system
infect
worst
complic
pneumonia
consid
diagnosi
neonat
pneumonia
age
diseas
onset
matern
histori
provid
valuabl
clue
potenti
pathogen
neonat
pneumonia
diagnos
base
combin
clinic
radiograph
laboratori
find
suction
sampl
tracheal
sputum
usual
contamin
commens
organ
prevent
definit
microbiolog
identif
pathogen
sputum
sampl
predomin
singl
bacteri
morphotyp
help
guid
initi
empir
therapi
congenit
pneumonia
frequent
compon
certain
torch
infect
consid
especi
set
system
diseas
hand
hygien
vap
bundl
evidencebas
approach
limit
occurr
lateonset
pneumonia
discoveri
biomark
identifi
pneumonia
especi
set
prematur
chronic
lung
diseas
make
pneumonia
harder
identifi
establish
role
microbiom
dysbiosi
pneumonia
pathogenesi
character
efficaci
differ
vap
bundl
element
understand
longterm
morbid
neonat
pneumonia
none
none
possibl
compon
neonat
ventilatorassoci
pneumonia
prevent
bundl
